‘Cortical Disarray Measurement (CDM)- A novel biomarker to indicate likelihood of progression to Alzheimer’s disease. Oxford University, Cardiff University and Southampton University in the development of a novel biomarker to diagnose dementia.
Supported
Dr Steven Chance, Carolyn Wallace PPI champion in Wales Team led by Robyn Davies
Oxford Brain Diagnostics Ltd